Nancy J. Cox, a renowned expert on influenza and its constantly mutating viruses, died on April 24 at her Atlanta home at the age of 77. As the longtime leader of the influenza program at the Centers for Disease Control and Prevention (CDC), she spearheaded the development of a global network for flu forecasting and prevention. Her husband, Evan Lindsay, stated that her death was caused by glioblastoma, an aggressive form of brain cancer.
Tracking influenza outbreaks is a complex endeavor, combining detective work with an urgent race against time and an element of prediction. Flu viruses constantly alter their genetic makeup, demanding that virologists scramble annually to develop new protocols and vaccines. Dr. Cox once told Time magazine in 2006, “When you work with an organism like influenza that’s ever-changing, you learn something new every year. So it never gets dull.” Keeping pace with such a formidable and elusive opponent necessitates a global infrastructure of scientists, forecasters, and policymakers. Over her nearly 40-year tenure at the CDC, Dr. Cox was instrumental in establishing and nurturing this essential network. Richard Webby, who directs influenza research at St. Jude Children’s Research Hospital, affirmed, “She was clearly one of the most influential people in the field of influenza and global public health for the past few decades.”
When Dr. Cox joined the CDC in Atlanta as a postdoctoral scholar in 1975, public health officials had limited tools for early detection of flu and other disease outbreaks, often forcing them into a reactive scramble once an epidemic was already widespread. This period marked a critical juncture in public health history. In January 1976, an ill-advised immunization rush exacerbated a deadly swine flu outbreak, utilizing a vaccine later linked to increased rates of Guillain-Barré syndrome, a nervous system disorder. Six months later, a pneumonia outbreak killed 34 people at an American Legion convention in Philadelphia, ultimately identified as Legionnaires’ disease, caused by a previously unknown bacterium. These two incidents underscored the urgent need for a robust institutional framework to track and respond to outbreaks, a mission that defined Dr. Cox’s career.
Dr. Cox expertly blended profound scientific knowledge, contributing to 278 academic papers, with astute policy instincts and a remarkable talent for institution-building. Upon her arrival, the CDC’s influenza branch comprised roughly a dozen individuals. By her retirement in 2014, it had expanded into its own division, employing approximately 350 staff and contractors. Walter Orenstein, an emeritus professor of medicine at Emory University and former colleague at the CDC, observed, “She understood everything from the micro to the macro.”
For public health officials, the primary challenge isn’t merely identifying influenza strains, but rather discerning which ones pose the most imminent threat of outbreak to effectively allocate limited resources. To facilitate these critical decisions, Dr. Cox developed a set of criteria informed by advancements in genetic sequencing technology. She also played a pivotal role in standardizing the annual flu vaccine design process. Furthermore, she pioneered a focus on zoonotic, or animal-borne, varieties of influenza, an approach that has been crucial in enabling officials to respond to major swine and avian flu outbreaks over the past three decades.
Dr. Cox was particularly dedicated to strengthening global resources, notably assisting China in establishing a world-class flu-monitoring network from its nascent stages. From 1992 to 2014, she led the CDC’s contribution to the World Health Organization’s (WHO) influenza tracking and response network. Julie Gerberding, CDC director from 2002 to 2009, commented, “She was someone who understood that viruses know no bounds. If you want to answer it, you have to have a global response.” This work was both monumental and unending; each year presented new challenges, regardless of the network’s previous successes. “I find the organism fascinating because of its ability to change and replicate in multiple different forms,” she shared with Government Executive magazine in 2006. “I haven’t gotten tired of influenza because there’s always something new.”
Nancy Jane Cox was born on July 21, 1948, in Emmetsburg, Iowa, to farmers Emmett and Verna (Olson) Cox. She pursued bacteriology as an undergraduate at Iowa State University, graduating at the top of her class in 1970. Awarded a Marshall Scholarship, she then studied at the University of Cambridge in England, earning a doctorate in virology in 1974. She began a postdoctoral program at the University of Maryland, Baltimore County, and subsequently followed her supervisor to the CDC.
Dr. Cox married Evan Lindsay in 1981. She is survived by her husband; their daughter, Julia Lindsay; a stepson, Mark Lindsay; a granddaughter; three step-grandchildren; her sister, Sherilyn Fuoss; and her brothers, Randolph, Richard, Robert, and Regan Cox. After retiring from the CDC, Dr. Cox continued to consult with the WHO and other international flu response efforts. She was widely admired for her precise, meticulous thinking, balanced by a keen, sardonic wit.
Source link